ProCipitate(tm)

LigoChem, a company based in Fairfield New Jersey, has introduced ProCipitate for the rapid and efficient isolation of nucleic acids. Based on patented Polymer Bridging Network technology, ProCipitate is one of a family of reagents with unique properties: Electropherosequence data of BAC DNA prepared by the TIGR ProCipitate Filterplate (TPF) method. Good quality DNA is consistently obtained with this method, which, using ABD BigDye Terminator sequencing chemistry -- yields high signal strength

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

LigoChem, a company based in Fairfield New Jersey, has introduced ProCipitate for the rapid and efficient isolation of nucleic acids. Based on patented Polymer Bridging Network technology, ProCipitate is one of a family of reagents with unique properties:


Electropherosequence data of BAC DNA prepared by the TIGR ProCipitate Filterplate (TPF) method. Good quality DNA is consistently obtained with this method, which, using ABD BigDye Terminator sequencing chemistry -- yields high signal strengths, low backgrounds and long reads.

LigoChem's ProCipitate AI Work: Protein binds witin the polymer matrix of ProCipitate while the unreacted nucleic acid is rejected into the supernatant.
It is an anionic, supercharged polymer, which in its initial state is fully extended. The introduction of protein causes the formation of salt bridges and the liberation of water. As the charge on the polymer is neutralized, the network literally collapses on itself, recoiling like a spring.

ProCipitate can be purchased ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies